Speakers

Mark Trusheim

Strategic Director, NEWDIGS Initiative Institute for Clinical Research and Health Policy Studies • Tufts Medical Center

Mark Trusheim is Strategic Director, NEWDIGS at Tufts Medical Center where he also co-leads the Financing and reimbursement of Cures in the US (FoCUS) Project; and a Visiting Scientist at the MIT Sloan School of Management.  Through MIT he has also served as a Special Government Employee for the FDA’s Office of the Commissioner. 

Mark’s research focuses on the economics of biomedical innovation, especially precision financing for patient access, precision medicine, adaptive pathways, platform trials, biosimilars, and digital health advances.

Mark is also President of Co-Bio Consulting, LLC. His career has spanned big data at Kenan Systems, marketing at Searle Pharmaceuticals, eHealth as Vice President of Monsanto Health Solutions, genomics as President of Cereon Genomics, and policy as the President of the Massachusetts Biotechnology Council.

He holds degrees in Chemistry from Stanford University and Management from MIT.

Also Speaking

James Kusena

Vice President, Bioprocessing & Applications • MicrofluidX

Andreas Kouri

Senior Vice President, Supply Chain Strategic Operations • ElevateBio

Yossi Schwartz

Professor, Pathology, Molecular and Cell Based Medicine at the Icahn School of Medicine • Mount Sinai Health System

Also Speaking

Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.
Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.